A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Name: A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
License: Public Domain

Anhui Provincial Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hepatocellular carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 407739
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.